Doxecitine and doxribtimine (MT1621)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Thymidine Kinase 2 (TK2) deficiency An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency Phase 2 TK0102
Ongoing 		NCT03845712
2018-004277-27
2023-510427-29-00